NCT05044286View on ClinicalTrials.gov

Longer-Acting PrEP in Transgender and Gender Diverse Texans

CompletedOBSERVATIONAL

Enrollment

565

Participants

Timeline

Start Date

February 1, 2022

Primary Completion Date

January 17, 2023

Study Completion Date

August 31, 2023

Conditions

HIV-1-infection

Interventions

OTHER

no intervention

no intervention

Trial Locations (1)

78712

The University of Texas at Austin, Austin

All Listed Sponsors

collaborator

Texas Health Institute

UNKNOWN

collaborator

Merck Sharp & Dohme LLC

INDUSTRY

collaborator

Transgender Education Network of Texas

UNKNOWN

lead

University of Texas at Austin

OTHER